Medios AG (XTER:ILM1) ROE % Adjusted to Book Value: 6.51% (As of Mar. 2026)

Medios AG XTER:ILM1 +1.47% 60 ROE % Adjusted to Book Value is 6.51% as of Mar. 2026. GuruFocus rates XTER:ILM1 with a GF Score™ of 60/100. The stock has 2 warning signs investors should review.

Medios AG's ROE % for the quarter that ended in Mar. 2026 was 3.84%. Medios AG's PB Ratio for the quarter that ended in Mar. 2026 was 0.59. Medios AG's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 6.51%.

Medios AG ROE % Adjusted to Book Value Related Terms

Medios AG ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Medios AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medios AG ROE % Adjusted to Book Value Chart

Medios AG Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

1.22

4.68

5.06

3.88

4.35

Medios AG Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															8.42	7.95	8.67	-5.10	6.51

XTER:ILM1 vs MCK, CAH, COR: ROE % Adjusted to Book Value Comparison

For the Medical Distribution subindustry, Medios AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medios AG ROE % Adjusted to Book Value vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medios AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Medios AG's ROE % Adjusted to Book Value falls into.

Save Embed

60GF Score

Medios AG XTER:ILM1

ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medios AG ROE % Adjusted to Book Value Calculation

Medios AG's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	3.00%	/	0.69
	=	4.35%

Medios AG's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	3.84%	/	0.59
	=	6.51%

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of 6.51% mean?

Medios AG (XTER:ILM1) has a ROE % Adjusted to Book Value of 6.51% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Medios AG and its competitors.

Is Medios AG's ROE % Adjusted to Book Value too high?

Medios AG's current ROE % Adjusted to Book Value is 6.51%. Overall, Medios AG has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.

How does Medios AG's ROE % Adjusted to Book Value compare to MCK and CAH?

Medios AG's ROE % Adjusted to Book Value of 6.51% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Medical Distribution company?

A good ROE % Adjusted to Book Value depends on the Medical Distribution industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Medios AG and its competitors. Medios AG's current ROE % Adjusted to Book Value is 6.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medios AG stock overvalued right now?

Medios AG (XTER:ILM1) has a current ROE % Adjusted to Book Value of 6.51%. The current ROE % Adjusted to Book Value is 6.51%. Medios AG's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For Medios AG (XTER:ILM1), the current ROE % Adjusted to Book Value is 6.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medios AG Business Description

Industry Healthcare Medical Distribution

Comparable Companies XTER:M12 STU:BMP MCK CAH COR ASX:SIG HSIC SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998 TSE:7459 OSTO:ASKER MIL:AMP SHSE:600511 IST:SELEC NZSE:EBO TSE:2784 SHSE:600739

Other Exchanges 0QB4:UK ILM1:Austria

Address Heidestrasse 9, Berlin, DEU, 10557

Website https://www.medios.ag

Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.

60GF Score

Get the complete analysis for XTER:ILM1

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.42

Price

View XTER:ILM1 Analysis

See ROE % Adjusted to Book Value data for all stocks →